EDNRA and systemic sclerosis: High levels of anti-AT1R and anti-ETAR antibodies have been reported to be associated with severe SSc vascular manifestations such as digital ulcers and PAH, and to be putative biomarkers to predict the development of such complications and overall mortality [67–69].